| 1 |
中华医学会器官移植学分会. 中国心脏死亡器官捐献工作指南(第2版)[J/CD]. 中华移植杂志：电子版，2012，6(3)：221-224.
|
| 2 |
国家卫生和计划生育委员会脑损伤质控评价中心. 脑死亡判定标准与技术规范(成人质控版)[J/CD]. 中华移植杂志：电子版，2015，9(1)：13-16.
|
| 3 |
国家卫生和计划生育委员会脑损伤质控评价中心. 脑死亡判定标准与技术规范(儿童质控版)[J/CD]. 中华移植杂志：电子版，2015，9(2)：5-8.
|
| 4 |
中华医学会器官移植学分会，中国医师协会器官移植医师分会. 体外膜肺氧合在中国公民逝世后捐献供器官保护中的应用专家共识(2016版)[J/CD]. 中华移植杂志：电子版，2016, 10(3): 107-111.
|
| 5 |
中华医学会器官移植学分会，中国医师协会器官移植医师分会. 中国公民逝世后捐献供器官功能评估和维护专家共识(2016版) [J/CD]. 中华移植杂志：电子版，2016, 10(4): 145-153.
|
| 6 |
文宁，张素斌，秦科，等. 早期目标液体复苏对脑死亡血流动力学及氧代谢的影响[J].广西医科大学学报，2011, 28(5): 700-702.
|
| 7 |
秦科，孙煦勇. 体外膜肺氧合技术在心脏死亡或脑死亡器官捐赠中应用的进展[J]. 中华器官移植杂志，2012, 33(11): 702-704.
|
| 8 |
Howick J, Chalmers I, Glasziou P, et al. Explanation of the 2011 Oxford Centre for evidence-based medicine (OCEBM) levels of evidence (background document) [EB/OL]. Oxford Centre for Evidence-Based Medicine, 2011.[2024-02-03].
URL
|
| 9 |
孙煦勇，秦科，董建辉，等. 体外膜肺氧合用于循环功能不稳定的中国一类捐赠者的器官保护三例[J]. 中华器官移植杂志，2012, 33(11): 657-660.
|
| 10 |
Bartlett RH, Gattinoni L. Current status of extracorporeal life support (ECMO) for cardiopulmonary failure[J]. Minerva Anestesiol, 2010，76(7)：534-540.
|
| 11 |
Le Gall A, Follin A, Cholley B, et al. Veno-arterial-ECMO in the intensive care unit: from technical aspects to clinical practice[J]. Anaesth Crit Care Pain Med, 2018, 37(3): 259-268.
|
| 12 |
Antoniucci ME, De Paulis S, Bevilacqua F, et al. Unconventional cannulation strategy in peripheral extracorporeal membrane oxygenation to achieve central perfusion and prevent differential hypoxia[J]. J Cardiothorac Vasc Anesth, 2019，33(5): 1367-1369.
|
| 13 |
Sekhon MS, Gooderham P, Menon DK, et al. The burden of brain hypoxia and optimal mean arterial pressure in patients with hypoxic ischemic brain injury after cardiac arrest[J]. Crit Care Med, 2019，47(7)：960-969.
|
| 14 |
Meyfroidt G, Gunst J, Martin-Loeches I, et al. Management of the brain-dead donor in the ICU: general and specific therapy to improve transplantable organ quality[J]. Intensive Care Med, 2019，45(3)：343-353.
|
| 15 |
秦科，孙煦勇，董建辉，等. 体外膜肺氧合对循环不稳定脑死亡器官捐献的肝肾功能修复效果[J]. 中华器官移植杂志，2017, 38(9): 525-530.
|
| 16 |
El-Battrawy I, Borggrefe M, Akin I. Myocardial dysfunction following brain death[J]. J Am Coll Cardiol, 2018, 71(3): 368.
|
| 17 |
Zetina-Tun H, Lezama-Urtecho C, Careaga-Reyna G. Terapia hormonal de rutina en el donador para trasplante cardiaco [Routine hormonal therapy in the heart transplant donor[J]. Cir Cir, 2016，84(3)：230-234.
|
| 18 |
Aljiffry M, Hassanain M, Schricker T, et al. Effect of insulin therapy using hyper-insulinemic normoglycemic clamp on inflammatory response in brain dead organ donors[J]. Exp Clin Endocrinol Diabetes, 2016, 124(5)：318-323.
|
| 19 |
Christopher DA, Woodside KJ. Expanding the donor pool: organ donation after brain death for extracorporeal membrane oxygenation patients[J]. Crit Care Med, 2017, 45(10): 1790-1791.
|
| 20 |
Yang HY, Lin CY, Tsai YT, et al. Experience of heart transplantation from hemodynamically unstable brain-dead donors with extracorporeal support[J]. Clin Transplant, 2012, 26(5): 792-796.
|
| 21 |
Kotloff RM, Blosser S, Fulda GJ, et al. Management of the Potential Organ Donor in the ICU: Society of Critical Care Medicine/American College of Chest Physicians/Association of Organ Procurement Organizations Consensus Statement[J]. Crit Care Med, 2015, 43(6): 1291-1325.
|
| 22 |
Stub D, Bernard S, Pellegrino V, et al. Refractory cardiac arrest treated with mechanical CPR, hypothermia, ECMO and early reperfusion (the CHEER trial) [J]. Resuscitation, 2015, 86: 88-94.
|
| 23 |
Cheema MA, Ullah W, Abdullah HM, et al. Duration of in-hospital cardiopulmonary resuscitation and its effect on survival[J]. Indian Heart J, 2019, 71(4): 314-319.
|
| 24 |
McKeown DW, Bonser RS, Kellum JA. Management of the heartbeating brain-dead organ donor[J]. Br J Anaesth. 2012，108(Suppl 1): i96-i107.
|
| 25 |
Brener MI, Rosenblum HR, Burkhoff D. Pathophysiology and advanced hemodynamic assessment of cardiogenic shock[J]. Methodist Debakey Cardiovasc J, 2020，16(1): 7-15.
|
| 26 |
Lee HH, Kim HC, Ahn CM, et al. Association between timing of extracorporeal membrane oxygenation and clinical outcomes in refractory cardiogenic shock[J]. JACC Cardiovasc Interv, 2021，14(10): 1109-1119.
|
| 27 |
Pang S, Miao G, Zhao X. Effects and safety of extracorporeal membrane oxygenation in the treatment of patients with ST-segment elevation myocardial infarction and cardiogenic shock: a systematic review and meta-analysis[J]. Front Cardiovasc Med, 2022, 9: 963002.
|
| 28 |
Combes A, Hajage D, Capellier G, et al. Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome[J]. N Engl J Med, 2018, 378(21): 1965-1975.
|
| 29 |
Chen CL, Wu ST, Kao CC, et al. Short-term result of renal transplantation using extracorporeal membrane oxygenation-supported brain-dead donors[J]. Transplant Proc, 2014, 46(4): 1061-1063.
|
| 30 |
Kang JH, Choi BH, Moon KM, et al. Beneficial effect of extracorporeal membrane oxygenation on organ perfusion during management of the unstable brain-dead donor: a Case Series[J]. Transplant Proc, 2016, 48(7): 2458-2460.
|
| 31 |
He S, Chen B, Li W, et al. Ventilator-associated pneumonia after cardiac surgery: a meta-analysis and systematic review[J]. Thorac Cardiovasc Surg, 2014，148(6): 3148-3155. e1-5.
|
| 32 |
国家卫生健康委员会脑损伤质控评价中心，中华医学会神经病学分会神经重症协作组，中国医师协会神经内科医师分会神经重症专业委员会. 脑死亡判定标准与操作规范：专家补充意见(2021)[J]. 中华医学杂志，2021，101(23)：1758-1765.
|
| 33 |
黄慧敏，王静，李易娟，等. 儿童体外膜肺支持下脑死亡判定[J]. 中国神经精神疾病杂志，2022，48(11)：664-669.
|
| 34 |
Casan J, Andrews RK, Gardiner EE, et al. Mechanisms of platelet dysfunction in patients with implantable devices[J]. Semin Thromb Hemost, 2018, 44(1): 12-19.
|
| 35 |
中华医学会器官移植学分会. 体外膜肺氧合用于尸体供器官保护的技术操作规范(2019版)[J]. 器官移植，2019, 10(4): 376-382.
|
| 36 |
Zhou AL, Leng A, Ruck JM, et al. Kidney donation after circulatory death using thoracoabdominal normothermic regional perfusion: the largest report of the United States experience[J]. Transplantation 2024，108(2)：516-523.
|
| 37 |
Altshuler PJ, Pace DJ, Preston WA, et al. Assessing kidney transplantation using ECMO-supported donors within a KDPI-based allocation system[J]. Transplant Direct, 2023，9(11)：e1521.
|
| 38 |
Johnson K, Jarboe MD, Mychaliska GB, et al. Is there a best approach for extracorporeal life support cannulation: a review of the extracorporeal life support organization[J]. J Pediatr Surg, 2018，53(7)：1301-1304.
|
| 39 |
Jensen AR, Davis C, Gray BW. Cannulation and decannulation techniques for neonatal ECMO[J]. Semin Fetal Neonatal Med, 2022，27(6)：101404.
|
| 40 |
Garcia AV, Jeyaraju M, Ladd MR, et al. Survey of the American Pediatric Surgical Association on cannulation practices in pediatric ECMO[J]. J Pediatr Surg, 2018, 53(9)：1843-1848.
|
| 41 |
Carpenter JL, Yu YR, Cass DL, et al. Use of venovenous ECMO for neonatal and pediatric ECMO: a decade of experience at a tertiary children′s hospital[J]. Pediatr Surg Int, 2018，34(3)：263-268.
|
| 42 |
Macchini F, Di Cesare A, Morandi A, et al. Surgical expertise in neonatal extracorporeal membrane oxygenation (ECMO): a single center experience[J]. Front Pediatr, 2019, 7：398.
|
| 43 |
Fu G, Wang Z, Zhao Y, et al. Application of extracorporeal membrane oxygenation in supporting organ transplant donors[J]. Int J Clin Exp Med, 2016, 9(6): 9327-9331.
|
| 44 |
Zeibi Shirejini S, Carberry J, McQuilten ZK，et al. Current and future strategies to monitor and manage coagulation in ECMO patients[J]. Thromb J, 2023, 21(1)：11.
|
| 45 |
Arepally GM. Heparin-induced thrombocytopenia[J]. Blood, 2017, 129(21)：2864-2872.
|
| 46 |
Rajsic S, Breitkopf R, Jadzic D, et al. Anticoagulation strategies during extracorporeal membrane oxygenation: a narrative review[J]. J Clin Med, 2022, 11(17)：5147.
|
| 47 |
Brogan, TV, Lequier L, Lorusso R, et al. Extracorporeal life support: The ELSO Red Book(5th ed)[M]. Extracorporeal Life Support Organization: Ann Arbor, MI, USA, 2017: 831
|
| 48 |
Fan X, Chen Z, Nasralla D, et al. The organ preservation and enhancement of donation success ratio effect of extracorporeal membrane oxygenation in circulatory unstable brain death donor[J]. Clin Transplant, 2016, 30(10)：1306-1313.
|
| 49 |
Kumar G, Maskey A. Anticoagulation in ECMO patients: an overview[J]. Indian J Thorac Cardiovasc Surg, 2021，37(Suppl 2): S241-S247.
|
| 50 |
中华医学会器官移植学分会. 中国公民逝世后器官捐献流程和规范(2019版) [J]. 器官移植，2019, 10(2): 122-127.
|
| 51 |
Zhou XL, Chen YH, Wang QY. A new approach combining venoarterial extracorporeal membrane oxygenation and CRRT for adults: a retrospective study[J]. Int J Artif Organs, 2017，40(7)：345-349.
|
| 52 |
Liu J, Dong YQ, Yin J, et al. Critically ill patients with COVID-19 with ECMO and artificial liver plasma exchange: a retrospective study[J]. Medicine (Baltimore), 2020，99(26)：e21012.
|
| 53 |
Schnuelle P, Gottmann U, Hoeger S, et al. Effects of donor pretreatment with dopamine on graft function after kidney transplantation: a randomized controlled trial[J]. JAMA, 2009，302(10)：1067-1075.
|
| 54 |
Lee JH, Hong SY, Oh CK, et al. Kidney transplantation from a donor following cardiac death supported with extracorporeal membrane oxygenation[J]. J Korean Med Sci, 2012，27(2)：115-119.
|
| 55 |
Pappalardo F, Montisci A. Veno-arterial extracorporeal membrane oxygenation (VA ECMO) in postcardiotomy cardiogenic shock: how much pump flow is enough？[J]. J Thorac Dis, 2016, 8(10)：E1444-E1448.
|
| 56 |
Villa G, Katz N, Ronco C. Extracorporeal membrane oxygenation and the kidney[J]. Cardiorenal Med, 2015，6(1)：50-60.
|
| 57 |
Fondevila C, Hessheimer AJ, Flores E, et al. Applicability and results of Maastricht type 2 donation after cardiac death liver transplantation[J]. Am J Transplant, 2012, 12(1)：162-170.
|
| 58 |
Fondevila C, Hessheimer AJ, Maathuis MH, et al. Superior preservation of DCD livers with continuous normothermic perfusion[J]. Ann Surg, 2011, 254(6)：1000-1007.
|
| 59 |
Hoffman JRH, McMaster WG, Rali AS, et al. Early US experience with cardiac donation after circulatory death (DCD) using normothermic regional perfusion[J]. J Heart Lung Transplant, 2021, 40(11)：1408-1418.
|
| 60 |
Barbero C, Messer S, Ali A, et al. Lung donation after circulatory determined death: a single-centre experience[J]. Eur J Cardiothorac Surg, 2019，55(2)：309-315.
|
| 61 |
Hagness M, Foss S, Sørensen DW, et al. Liver transplant after normothermic regional perfusion from controlled donors after circulatory death: the Norwegian experience[J]. Transplant Proc, 2019，51(2)：475-478.
|
| 62 |
Ghimessy ÁK, Farkas A, Gieszer B, et al. Donation after cardiac death, a possibility to expand the donor pool: review and the hungarian experience[J]. Transplant Proc, 2019, 51(4)：1276-1280.
|
| 63 |
Del Río F, Andrés A, Padilla M, et al. Kidney transplantation from donors after uncontrolled circulatory death: the Spanish experience[J]. Kidney Int, 2019，95(2)：420-428.
|
| 64 |
Assalino M, Majno P, Toso C, et al. In situ liver splitting under extracorporeal membrane oxygenation in brain-dead donor[J]. Am J Transplant, 2018, 18(1)：258-261.
|
| 65 |
Reeb J, Keshavjee S, Cypel M. Successful lung transplantation from a donation after cardiocirculatory death donor taking more than 120 minutes to cardiac arrest after withdrawal of life support therapies[J]. J Heart Lung Transplant, 2016，35(2)：258-259.
|
| 66 |
Bronchard R, Durand L, Legeai C, et al. Brain-dead donors on extracorporeal membrane oxygenation[J]. Crit Care Med, 2017, 45(10)：1734-1741.
|
| 67 |
De Vleeschauwer SI, Wauters S, Dupont LJ, et al. Medium-term outcome after lung transplantation is comparable between brain-dead and cardiac-dead donors[J]. J Heart Lung Transplant, 2011, 30(9)：975-981.
|
| 68 |
Hosgood SA, Nicholson HF, Nicholson ML. Oxygenated kidney preservation techniques[J]. Transplantation, 2012, 93(5)：455-459.
|
| 69 |
Perrault LP, Carrier M. Expanding the pool of cardiac donors: is it really possible after cardiac arrest？[J]. J Thorac Cardiovasc Surg, 2017，153(3)：631.
|
| 70 |
Ellert J, Jensen MJ, Jensen LO, et al. Percutaneous biventricular cardiac assist device in cardiogenic shock and refractory cardiac arrest[J]. EuroIntervention, 2018，13(18)：e2114-e2115.
|
| 71 |
Rady MY, Verheijde JL. Prediction of time to death after terminal withdrawal of life-support in non-heartbeating organ donation: unaccounted variables and window of opportunity*[J]. Crit Care Med, 2012, 40(3)：986-988.
|
| 72 |
Reich DJ, Mulligan DC, Abt PL, et al. ASTS recommended practice guidelines for controlled donation after cardiac death organ procurement and transplantation[J]. Am J Transplant, 2009，9(9)：2004-2011.
|
| 73 |
Ortega-Deballon I, Hornby L, Shemie SD. Protocols for uncontrolled donation after circulatory death: a systematic review of international guidelines, practices and transplant outcomes[J]. Crit Care, 2015，19(1)：268.
|
| 74 |
Youn TS, Greer DM. Brain death and management of a potential organ donor in the intensive care unit[J]. Crit Care Clin, 2014，30(4)：813-831.
|
| 75 |
Fondevila C． Is extracorporeal support becoming the new standard for the preservation of DCD grafts？[J]. Am J Transplant, 2010，10(6): 1341-1342.
|
| 76 |
Hoogland ER, Snoeijs MG, van Heurn LW. DCD kidney transplantation: results and measures to improve outcome[J]. Curr Opin Organ Transplant, 2010, 15(2)：177-182.
|
| 77 |
霍枫，汪邵平，李鹏，等. 体外膜肺氧合用于心死亡供肝的初步经验[J]. 中华肝胆外科杂志，2012, 18(5): 354-356.
|
| 78 |
Kerforne T, Allain G, Giraud S, et al. Defining the optimal duration for normothermic regional perfusion in the kidney donor: a porcine pre- clinical study[J]. Am J Transplant, 2019, 19(3): 737-751.
|
| 79 |
Barbier L, Guillem T, Savier E, et al. Impact of the duration of normothermic regional perfusion on the results of liver transplant from controlled circulatory death donors: a retrospective, multicentric study[J]. Clin Transplant, 2022, 36(2): e14536.
|
| 80 |
Suberviola B, Mons R, Ballesteros MA, et al. Excellent long-term outcome with lungs obtained from uncontrolled donation after circulatory death[J]. Am J Transplant, 2019，19(4)：1195-1201.
|
| 81 |
Thuillier R, Favreau F, Celhay O, et al. Thrombin inhibition during kidney ischemia-reperfusion reduces chronic graft inflammation and tubular atrophy[J]. Transplantation, 2010, 90(6)：612-621.
|
| 82 |
Hansen D, Rørvig S, Andersen CB, et al. Fibrin thrombi in deceased donor kidneys: prevalence and influence on graft function and graft survival in transplanted patients[J]. APMIS, 2018，126(1)：3-8.
|
| 83 |
中国肝移植注册中心，国家肝脏移植质控中心，国家人体捐献器官获取质控中心，等. 中国移植器官保护专家共识(2022版)[J/CD]. 中华移植杂志：电子版，2022，16(1)：1-12.
|
| 84 |
隋明昊，刘蕾，沈中阳. 体外膜肺氧合技术及其在心死亡器官捐献中的应用进展[J]. 山东医药，2015 (34)：101-103.
|
| 85 |
Mandawat A, Rao SV. Percutaneous mechanical circulatory support devices in cardiogenic shock[J]. Circ Cardiovasc Interv, 2017, 10(5)：e004337.
|
| 86 |
Magliocca JF, Magee JC, Rowe SA, et al. Extracorporeal support for organ donation after cardiac death effectively expands the donor pool[J]. J Trauma, 2005, 58(6)：1095-1102.
|
| 87 |
Rojas-Peña A, Sall LE, Gravel MT, et al. Donation after circulatory determination of death: the university of michigan experience with extracorporeal support[J]. Transplantation, 2014，98(3)：328-334.
|
| 88 |
Oniscu GC, Randle LV, Muiesan P, et al. In situ normothermic regional perfusion for controlled donation after circulatory death-the United Kingdom experience[J]. Am J Transplant, 2014，14(12)：2846-2854.
|
| 89 |
Herdman R, Beauchamp TL, Potts JT. The institute of medicine′s report on non-heart-beating organ transplantation[J]. Kennedy Inst Ethics J, 1998, 8(1)：83-90.
|
| 90 |
Okazaki M, Date H, Inokawa H, et al. Optimal time for post-mortem heparinization in canine lung transplantation with non-heart-beating donors[J]. J Heart Lung Transplant, 2006, 25(4)：454-460.
|
| 91 |
Rojas-Pena A, Hall CM, Cook KE, et al. Timing of heparin and perfusion temperature during procurement of organs with extracorporeal support in donors after circulatory determination of death[J]. ASAIO J, 2011, 57(5)：368-374.
|
| 92 |
中华医学会器官移植学分会. 尸体器官捐献供体及器官评估和维护规范(2019版)[J]. 器官移植，2019，10(3)：253-262.
|
| 93 |
袁润强，宫满成，董文静，等. 体外膜肺氧合减轻脑死亡后循环功能不稳定供肾损伤的研究[J]. 中华器官移植杂志，2018, 39(4): 213-216.
|
| 94 |
丘小红，刘少儒，许磊波，等. 体外膜肺氧合在供者维护中的应用进展[J]. 器官移植，2020, 11(6): 658-662.
|
| 95 |
霍枫，李鹏，汪邵平. 体外膜肺氧合在心脏死亡器官捐献中的应用[J]. 中华消化外科杂志，2013, 12(9): 648-651.
|
| 96 |
霍枫，汪邵平，李鹏，等. 体外膜肺氧合用于脑心双死亡供者器官获取的流程和方法[J]. 中华器官移植杂志，2013, 34(7): 396-400.
|